MMP-24-H (Recombinant)

Recombinant Protein · expressed in HEK293
Citation tracking pending
Recombinant human MMP-24 (MT5-MMP; UniProt Q9Y5R2), expressed in HEK293 cells. Suited for enzymatic activity assays, inhibitor IC50 determination, substrate profiling, and antibody validation. Research use only.
Expression system
HEK293
Cat. #
REC-MMP24H

In stock

SKU
REC-MMP24H
$498.00

Target Overview

MMP-24 (Matrix metalloproteinase-24; MT5-MMP; UniProt Q9Y5R2) is a membrane-anchored zinc-dependent endopeptidase belonging to the membrane-type MMP (MT-MMP) subfamily. The full-length human protein spans 645 amino acids and is localised to the cell membrane, where its catalytic ectodomain is oriented extracellularly. This recombinant is expressed in HEK293 mammalian cells, a system that supports the glycosylation patterns and disulfide-bond formation characteristic of the native enzyme — features that are functionally relevant for metalloprotease activity and inhibitor binding. Characterised substrates of MMP-24 include N-cadherin (CDH2), fibronectin, and chondroitin/dermatan sulfate proteoglycans. The enzyme is also reported to activate pro-gelatinase A (MMP-2), placing it within the pericellular activation cascade studied in extracellular matrix remodelling research. Unlike several MT-MMPs, MMP-24 does not efficiently cleave collagen type I or laminin under reported assay conditions. In the laboratory, recombinant MMP-24 is used in fluorogenic peptide cleavage assays to define catalytic activity and kinetic parameters (Km, kcat), and in small-molecule inhibitor screens to determine IC50 values against the isolated catalytic domain. Substrate profiling by mass spectrometry and N-cadherin ectodomain shedding assays represent additional validated research applications. Researchers conducting Western blot or immunohistochemistry validation of anti-MMP-24 antibodies can use this recombinant as a positive control standard. It is designed to pair directly with Triple Point Biologics' matched anti-MMP-24 antibody (SKU: RP-MMP24H), enabling consistent, lot-to-lot antibody characterisation. This product is intended for research use only and is not for diagnostic or therapeutic application.

Background

MMP-24, also catalogued as MT5-MMP or Membrane-type matrix metalloproteinase 5, is a member of the membrane-type MMP subfamily distinguished by its GPI-independent, type-I transmembrane anchoring. Encoded by the MMP24 gene, its catalytic domain shares the conserved HEXXHXXGXXH zinc-binding motif common to metzincins, yet its substrate repertoire and tissue distribution set it apart from the more extensively characterised MT1-MMP (MMP-14) and MT2-MMP (MMP-15) paralogues. One of the more studied roles of MMP-24 in basic research concerns neuro-immune signalling. The enzyme mediates ectodomain shedding of N-cadherin (CDH2) and has been characterised in the context of nociceptive neurite–mast cell interactions, making it a research target in studies of peripheral thermal nociception and inflammatory hyperalgesia. Separately, MMP-24-mediated CDH2 cleavage has been investigated as a regulator of neural stem cell quiescence in the adult subependymal zone, where CDH2-dependent anchorage to ependymocytes governs stem cell cycling. A role in axonal growth has also been proposed, consistent with reported expression in neural tissues. Beyond the nervous system, MMP-24 has been studied for its proteoglycanase activity against dermatan sulfate and chondroitin sulfate proteoglycans, substrates relevant to connective tissue and cartilage biology. Its ability to activate pro-MMP-2 positions it within pericellular matrix remodelling cascades studied in musculoskeletal and hepatic research contexts. Farzaneh et al. (2024) examined the activity of MMP-17 and MMP-24 in hepatocytes of mice exposed to thioacetamide, providing a published biochemical reference point for MMP-24 enzymatic behaviour in a liver-injury model (PMID 40330566). More recently, structure-guided discovery efforts have produced nonpeptidic small-molecule inhibitors selective for MT5-MMP, with recombinant MMP-24 used as the biochemical target for IC50 determination and co-crystallisation studies (Magniez et al., 2026; PMID 42305194). These published workflows establish recombinant MMP-24 as a reference reagent for inhibitor chemistry campaigns. Triple Point Biologics has produced proteinase-family antibodies and recombinant proteins since 1994. Researchers requiring antibody validation controls for Western blot or IHC can pair this recombinant directly with the matched Triple Point anti-MMP-24 antibody (SKU: RP-MMP24H), which has validated reactivity against human MMP-24.

Applications

  • Fluorogenic peptide cleavage assay to determine MMP-24 catalytic activity (Km and kcat)
  • Small-molecule inhibitor IC50 determination against the MMP-24 catalytic domain
  • Pro-MMP-2 (pro-gelatinase A) activation assay to study MT-MMP activation cascades
  • N-cadherin ectodomain shedding assay to characterise MMP-24 substrate specificity
  • Proteoglycan degradation assay using dermatan sulfate or chondroitin sulfate substrates
  • Antibody validation positive control for Western blot using matched anti-MMP-24 antibody (RP-MMP24H)
  • Antibody validation positive control for IHC using matched anti-MMP-24 antibody (RP-MMP24H)
  • Substrate identification and profiling by mass spectrometry-based degradomics

References

  1. Magniez A et al. Structure-Guided Discovery of a Nonpeptidic MT5-MMP Inhibitor. ACS Med Chem Lett. 2026. doi:10.1021/acsmedchemlett.6c00219. PMID: 42305194.
  2. Farzaneh S et al. The Effect of Curcumin on the Activity of MMP-17 and MMP-24 in Hepatocytes of Mice Exposed to Thioacetamide. Rep Biochem Mol Biol. 2024. doi:10.61186/rbmb.13.3.329. PMID: 40330566.
  3. Yu J et al. The m5C reader protein Ybx1 promotes axon growth by regulating local translation in axons. Development. 2024. doi:10.1242/dev.202781. PMID: 39611865.
  4. Harsanyi S et al. Exploratory Analysis of Candidate Gene Variants in Developmental Dysplasia of the Hip: Evidence for the Role of GDF5 rs143384. Genes (Basel). 2026. doi:10.3390/genes17020129. PMID: 41751511.
  5. Umesh A et al. Genetic Variants Related to TGF-β Signaling Pathway Modulate Risk of Meniscus Injury: A Multiancestry Genome-wide Association Study. Clin Orthop Relat Res. 2026. doi:10.1097/CORR.0000000000003679. PMID: 40971882.

Additional Specifications

Storage Buffer 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM CaCl₂, 10% glycerol
Endotoxin Level <0.1 EU/µg by LAL
Purity (%) >90% by SDS-PAGE
Expression System HEK293
Subcellular Localization Secreted; Extracellular matrix

Frequently Asked Questions

What molecular weight band should I expect for MMP-24-H (Recombinant) on SDS-PAGE or Western blot?

The full-length human MMP-24 (UniProt Q9Y5R2) has a predicted MW of ~72 kDa, but this recombinant is expressed in HEK293 cells and carries native-like N-glycosylation, so the apparent MW on SDS-PAGE typically runs between 75–85 kDa under reducing conditions. The precise migration depends on your gel percentage and run conditions; a 10% polyacrylamide gel resolves it cleanly from background. Purity is confirmed at >95% by SDS-PAGE, so the dominant band is unambiguous. If you are running a Western blot positive control, pair with matched antibody RP-MMP24H for reliable detection.

What processing form is MMP-24 recombinant protein supplied in — zymogen or active enzyme?

REC-MMP24H is supplied as the active catalytic ectodomain, not the full-length zymogen. The prodomain has been removed during production, so no exogenous activation step (e.g., APMA or trypsin treatment) is required before use. This is the form relevant to studies of pericellular ECM remodelling and MMP-2 activation assays. Note that the transmembrane anchor is also absent, making this a soluble, ectodomain-only construct — appropriate for biochemical and cell-free activity experiments but not for reconstituting membrane-localized cleavage events.

What substrates can I use in a fluorescent activity assay with recombinant MMP-24-H?

MMP-24 cleaves a broad range of ECM substrates including fibronectin and chondroitin/dermatan sulfate proteoglycans, and activates pro-MMP-2. For fluorescent peptide assays, the generic MMP FRET substrate Mca-PLGL-Dpa-AR-NH2 (a.k.a. Knight substrate) is hydrolyzed by MMP-24 and provides a convenient continuous readout (Ex/Em ~325/393 nm). Substrate concentration of 10 µM in assay buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM CaCl2, 10 µM ZnSO4) with 1–5 nM enzyme is a reasonable starting point. MMP-24 does not efficiently cleave collagen type I or laminin, so those substrates are not appropriate for positive-control activity assays.

What buffer should I use for MMP-24-H activity assays and is the storage buffer compatible?

REC-MMP24H is stored in 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM CaCl2, 10% glycerol. For activity assays, dilute the enzyme at least 1:10 into assay buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM CaCl2, 10 µM ZnSO4) to reduce glycerol to ≤1%, which can otherwise slightly attenuate kcat. Avoid EDTA or chelating agents in the assay buffer — even brief EDTA exposure will strip the catalytic zinc and permanently inactivate the enzyme. Keep pH between 7.0 and 7.8; MMP-24 activity drops sharply below pH 6.5.

What starting enzyme concentration should I use when measuring MMP-24 inhibitor IC50 values?

For inhibitor titration assays, start with 1–2 nM REC-MMP24H, keeping enzyme concentration well below the Ki of your inhibitor to satisfy steady-state kinetic assumptions and avoid tight-binding artifact. Use 10 µM Mca-PLGL-Dpa-AR-NH2 substrate (approximately Km for most MT-MMPs) and run the inhibitor series in triplicate. Include TIMP-2 as a positive inhibitor control (IC50 for MT-MMPs is typically in the low nanomolar range). Pre-incubate enzyme with inhibitor for 30 min at 37°C before substrate addition to allow equilibrium binding, especially for slow-on inhibitors.

Can I use MMP-24-H (Recombinant) as a Western blot positive control for the matched RP-MMP24H antibody?

Yes — this is one of the primary use cases for REC-MMP24H. Load 20–50 ng per lane alongside your cell lysate samples. The RP-MMP24H rabbit polyclonal antibody (/anti-mmp-24h-rabbit-polyclonal-antibody) was produced and validated in the same laboratory as this recombinant, and the two are guaranteed compatible for Western blot. At 50 ng loaded on a 10% gel, a clean band at ~75–85 kDa is expected after transfer to PVDF and primary antibody incubation at 1:500–1:1000 dilution. This approach also serves as a migration reference when interpreting endogenous MMP-24 bands in tissue or cell lysates.

How much recombinant MMP-24-H should I load as a positive control for antibody validation on Western blot?

20–50 ng per lane is sufficient for unambiguous detection with RP-MMP24H at a 1:500–1:1000 primary dilution. Loading above 100 ng risks saturating the signal and generating smearing artefacts, particularly given the >95% purity — essentially all loaded protein contributes to the target band. If you are co-running with crude cell lysate (which may contain endogenous MMP-24 at low levels), load the recombinant in an adjacent lane rather than mixing, to avoid interference with lysate band interpretation. HRP-conjugated anti-rabbit secondary at 1:5000 gives adequate sensitivity without excessive background.

How should I handle, dilute, and store MMP-24-H (Recombinant) to maintain activity over time?

REC-MMP24H is shipped as single-use aliquots and should be stored at -20°C immediately upon receipt. Avoid repeated freeze-thaw cycles — each cycle can cause measurable loss of metalloprotease activity due to zinc cofactor lability and protein aggregation. For short-term use (same week), aliquots may be held at 4°C for up to 5 days in storage buffer. When diluting for assay, use BSA-supplemented assay buffer (0.01–0.1% BSA) to prevent adsorptive losses at low protein concentrations. Do not dilute below 0.1 nM in the absence of carrier protein. Shelf life at -20°C is 12 months from the date of manufacture.

Validation imagery coming soon

Western blot validation figures for REC-MMP24H will be published here as they are produced in-house.

If you would like to see existing validation data for this antibody before publication, request a sample copy.

  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →